Utility of Cardiac Monitoring in Fetuses at Risk for Congenital Heart Block
Top Cited Papers
- 29 January 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 117 (4) , 485-493
- https://doi.org/10.1161/circulationaha.107.707661
Abstract
Background— Anti-SSA/Ro–associated third-degree congenital heart block is irreversible, prompting a search for early markers and effective therapy. Methods and Results— One hundred twenty-seven pregnant women with anti-SSA/Ro antibodies were enrolled; 95 completed an evaluable course in 98 pregnancies. The protocol included fetal echocardiograms performed weekly from 16 to 26 weeks’ gestation and biweekly from 26 to 34 weeks. PR intervals >150 ms were considered prolonged, consistent with first-degree block. Ninety-two fetuses had normal PR intervals. Neonatal lupus developed in 10 cases; 4 were neonatal lupus rash only. Three fetuses had third-degree block; none had a preceding abnormal PR interval, although in 2 fetuses >1 week elapsed between echocardiographic evaluations. Tricuspid regurgitation preceded third-degree block in 1 fetus, and an atrial echodensity preceded block in a second. Two fetuses had PR intervals >150 ms. Both were detected at or before 22 weeks, and each reversed within 1 week with 4 mg dexamethasone. The ECG of 1 additional newborn revealed a prolonged PR interval persistent at 3 years despite normal intervals throughout gestation. No first-degree block developed after a normal ECG at birth. Heart block occurred in 3 of 16 pregnancies (19%) in mothers with a previous child with congenital heart block and in 3 of 74 pregnancies (4%) in mothers without a previous child with congenital heart block or rash ( P =0.067). Conclusions— Prolongation of the PR interval was uncommon and did not precede more advanced block. There was a trend toward more congenital heart block in fetuses of women with previously affected offspring than those without previously affected offspring. Advanced block and cardiomyopathy can occur within 1 week of a normal echocardiogram without initial first-degree block. Echodensities and moderate/severe tricuspid regurgitation merit attention as early signs of injury.Keywords
This publication has 36 references indexed in Scilit:
- Fetal ECG: a novel predictor of atrioventricular block in anti-Ro positive pregnanciesHeart, 2007
- Treatment of fetal heart block with maternal steroid therapy: case report and review of the literatureUltrasound in Obstetrics & Gynecology, 2004
- Concomitant disappearance of electrocardiographic abnormalities and of acquired maternal autoantibodies during the first year of life in infants who had QT interval prolongation and anti‐SSA/Ro positivity without congenital heart block at birthArthritis & Rheumatism, 2003
- Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus GroupAnnals of the Rheumatic Diseases, 2002
- Transient neonatal bradycardia without heart block associated with anti-Ro antibodiesLupus, 1997
- The 52‐kd protein as a target of intermolecular spreading of the immune response to components of the SS‐A/Ro‐SS‐B/La complexArthritis & Rheumatism, 1997
- Anti–Ro/SS‐A and Anti–La/SS‐B autoantibody levels in relation to systemic lupus erythematosus disease activity and congenital heart blockArthritis & Rheumatism, 1992
- Echocardiographic evaluation of dilated cardiomyopathy in the human fetusThe American Journal of Cardiology, 1989
- Normal ECG standards for infants and childrenPediatric Cardiology, 1980
- The transplacental passage of prednisone and prednisolone in pregnancy near termThe Journal of Pediatrics, 1972